http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).
-
EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities
-
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic
-
EXMceuticals Inc. Announces Shares for Debt Settlement
-
EXMceuticals Inc. Announces Loan Settlement and Share Issuance
-
EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation’s Balance Sheet
-
EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate
-
EXMceuticals Inc. Receives 45-Day Extension to File Quarterly Financial Statements
-
EXMceuticals Inc. Secures Supply & Offtake Agreements-In-Principle for Proposed Portugal Refinery
-
EXMceuticals Inc. provides an update on operations and announces first closing of loan agreement
-
EXMceuticals Inc. provides an update on activities and announces a new Board Member and Corporate Secretary
-
EXMceuticals Inc. appoints Michael Kinley as CFO
-
EXMceuticals Inc. appoints Michael Kinley as CFO
-
EXMceuticals Inc. appoints Prf. Dr. Eurico Castro Alves as Board Advisor
-
EXMceuticals Inc. appoints Prf. Dr. Eurico Castro Alves as Board Advisor
-
EXMceuticals Inc. appoints Nick Davis as Board Advisor
-
EXMceuticals Provides Bi-Weekly Default Status Report
-
EXMceuticals Provides Bi-Weekly Default Status Report
-
EXMceuticals Granted Management Cease Trade Order
-
EXMceuticals inc. applies for a for a voluntary management cease trade order
-
EXMceuticals obtains its research and development license for its TecLab facilities in Portugal
-
EXMceuticals Inc. appoints cannabis industry leader Tripp Keber as Strategic Advisor to the Board

